Author:
Imai T., ,Tanaka S.,Kawakami K.,Miyazaki T.,Hagino H.,Shiraki M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference38 articles.
1. Mithal A, Ebeling P, Kyer CS (2013) Asia-Pacific Regional Audit: epidemiology, costs & burden of osteoporosis in 2013. International Osteoporosis Foundation, Nyon
2. Tosteson ANA, Melton LJ III, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447
3. Stevenson MD, Selby PL (2014) Modelling the cost effectiveness of interventions for osteoporosis: issues to consider. PharmacoEconomics 32:735–743
4. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118:622–629
5. Tosteson ANA, Hammond CS (2002) Quality-of-life assessment in osteoporosis: health-status and preference-based measures. PharmacoEconomics 20:289–303
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献